MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30.

Income Overview

Net Income
-$5,490K
EPS
-$0.24
Unit: Thousand (K) dollars

Income Statement
2025-06-30
2024-12-31
2024-09-30
Research and development
-12,922* 14,424
General and administrative
-4,558* 3,944
Total operating expenses
-17,480 18,368
Loss from operations
--17,480* -18,368
Other income, net
-134* 520
Net loss before income taxes
--17,346* -17,848
Other segment expense
218 --
Research and development-TIDAL-01
-48 --
Research and development-Compensation
406 --
Other income, net
81 --
Provision for income taxes
12 --
General and administrative
5,388 --
Benefit (provision) for income taxes
-2,485* -816
Depreciation expense
31 --
Net loss
-5,490 -19,831 -17,032
Oci, debt securities, available-for-sale, gain (loss), before adjustment, after tax, total
--30
Net loss attributable to common stockholders, basic
--19,831 -
Comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest
---17,002
Net loss attributable to common stockholders, diluted
--19,831 -
Basic EPS
-0.24 -0.861 -0.74
Diluted EPS
-0.24 -0.861 -0.74
Basic Average Shares
23,140,510 23,036,442 23,037,714
Diluted Average Shares
23,140,510 23,036,442 23,037,714
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$5,490K Other segment expense$218K Other income, net$81K Research anddevelopment-TIDAL-01-$48K General andadministrative$5,388K Research anddevelopment-Compensation$406K Depreciation expense$31K Provision for income taxes$12K

Turnstone Biologics Corp. (TSBX)

Turnstone Biologics Corp. (TSBX)